Kinjal Kashyap, Pharm.D.
About Kinjal Kashyap, Pharm.D.
Kinjal Kashyap, Pharm.D., is the Associate Director of Global Risk Management for Solid Tumor Oncology at Bristol Myers Squibb in Princeton, New Jersey. She has extensive experience in global risk management and pharmacovigilance, having previously worked at Novartis, Bayer HealthCare, and Rutgers University.
Company
Kinjal Kashyap is currently working at Bristol Myers Squibb as the Associate Director of Global Risk Management for Solid Tumor Oncology. The company is located in Princeton, New Jersey, United States. Bristol Myers Squibb is known for its focus on cancer treatment, cardiovascular health, and immune disease therapies.
Title
Kinjal Kashyap holds the position of Associate Director, Global Risk Management - Solid Tumor Oncology at Bristol Myers Squibb. In this role, he is responsible for managing safety profiles and risk management strategies for oncology products.
Education and Expertise
Kinjal Kashyap earned his Doctor of Pharmacy (Pharm.D.) degree from Rutgers University, where he studied from 2006 to 2012. Throughout his career, he has developed extensive expertise in global risk management, particularly in the field of solid tumor oncology. This includes the development and implementation of risk management plans for oncology products.
Career Background
Before joining Bristol Myers Squibb, Kinjal Kashyap worked at Novartis as a Global Risk Management Plan (RMP) Manager from 2014 to 2021 in East Hanover, New Jersey. He also held the position of Rutgers Post-Doctoral Fellow in Global Drug Safety/Pharmacovigilance at Bayer HealthCare from 2012 to 2014 in Whippany, New Jersey. His early career included roles as an Adjunct Faculty member at Rutgers University and various externships and internships in medical communications, medical information, and pharmacovigilance.
Previous Positions
Kinjal Kashyap accumulated diverse experience through multiple roles including a Medical Communications Extern at Tricore Interactive in 2011, a Medical Information Extern at Novo Nordisk A/S in 2011, and a Pharmacy Intern at CVS Pharmacy from 2007 to 2012. Additionally, he served twice as a Pharmacovigilance Intern at Aurobindo Pharma U.S.A. in 2010 and 2011.